Send us an emailLonza
COMPANY DETAILS
Muenchensteinerstrasse 38
Basel
4002
Switzerland
+41 61 316 8111
HEALTH CATEGORIES
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.
NUTRITION & HEALTH NEWS
23 Mar 2023 --- The UN declared this decade – from 2021 to 2030 – “The Decade of Healthy Aging,” and many leading developers and suppliers within the segment agree it is a... Read More
NUTRITION & HEALTH NEWS
16 Mar 2023 --- Sports nutrition has transitioned beyond the realms of professional athletes to the everyday consumer, spurred by the overriding industry themes of health consciousness and more... Read More
NUTRITION & HEALTH NEWS
06 Feb 2023 --- Major ingredients suppliers are expecting a wave of innovation in the supplements industry in the next five years, spurred by new digital technologies, emerging market... Read More
NUTRITION & HEALTH NEWS
02 Feb 2023 --- The transformation of well-being as a pure reflection of exterior looks to gut health, mental health and personal nutrition are all areas becoming more and more present in the... Read More
NUTRITION & HEALTH NEWS
23 Jan 2023 --- The supplement market’s proliferation is being driven by mega-trends toward holistic well-being, beauty-from-within and immunity support in the aftermath of a global pandemic.... Read More
20 Jun 2022 --- TWK10® sports probiotic is an innovative strain L. plantarum and is the first probiotic clinically proven to increase exercise endurance by up to 75% in athletes of all levels. Learn how TWK10® sports probiotic can help you break through in the competitive global sports and active nutrition categories.This Video is from Lonza.
16 May 2022 --- Amid toughening regulations surrounding titanium dioxide (TiO2) as a whitening ingredient, Lonza is expanding its Capsugel offering to meet TiO2-free requirements for food supplements in the EU. The company’s global product manager Julien Lamps details the opportunities and challenges surrounding the opacifying technology.
15 Mar 2022 --- In light of the EU’s ban on titanium dioxide, Anne Holderbach explores Lonza’s alternatives for capsules, which use iron oxide for an opaque effect and moderate UV protection. In terms of more vivid semi-opaque options, the company has also developed food-colored capsules.
31 May 2021 --- The “unharmonized” probiotics scene contributes to consumer confusion, which has motivated Chr. Hansen to launch a global online version of The Probiotics Institute. The one-stop-shop educational platform helps consumers navigate the “probiotics jungle” and demystify the human microbiome. Linda Neckmar, VP of commercial development, details why the company has developed a separate version for the Chinese market and how the move coincides with wider company strategies.
22 Dec 2020 --- General health with an emphasis on digestion is set to reach new heights over the coming years as new research emerges, according to Roel van de Put, Lonza Capsules and Health Ingredients’ business development manager. Beauty-from-within, mobility, mood health and immunity will also be major forces shaping the nutritional realm, he predicts.
05 Dec 2022 --- For supplement and nutraceutical brands, there’s no better time to seize the booming joint health market opportunity. Download Lonza’s NEW eBook to discover what consumers want, and how to capture market share and consumer attention in the dynamic joint health category with UC-II® undenatured type II collagen.This Technical Paper is from Lonza.
19 Apr 2022 --- TWK10® sports probiotic is an innovative strain L. plantarum and is the first probiotic clinically proven to increase exercise endurance by up to 75% in athletes of all levels.Learn how TWK10® sports probiotic can help you break through in the competitive global sports and active nutrition categories.This Technical Paper is from Lonza.
Consumers are increasingly looking for plant-based offerings and supplements are no exception. Plant-based or vegan claims on supplements grew by 34 percent between 2015 and 2019 and show no... Read More
While differing generations have unique nutritional priorities, they share a desire to live healthy and less stressed lives. This has led many to turn to supplements as an easy way to... Read More
Clean label remains king in the supplement space, as consumers who are wary of ingredient traceability and safety are drawn to shorter label lists. Concerns from consumers and lobby groups... Read More
The aging consumer has growing expectations of bone and joint health solutions, thanks to the mainstreaming of sports nutrition and a growing focus on active aging. According to Innova... Read More
Products featuring bone & joint health claims are on the rise, with Innova Market Insights data showing a compound annual growth rate of 13 percent between 2013 and... Read More
21 Feb 2022 --- Today’s NewsBite Podcast details Lonza’s sports probiotic launching in the EU. DSM announced two of its probiotic strains received New Dietary Ingredient status from the FDA, while Calocurb is developing its hop extract Amarasate into a functional food additive that can help suppress appetite.
07 Jun 2021 --- This NewsBite podcast delves into Chr. Hansen and Lonza’s joint venture, Bacthera, receiving manufacturing licenses to start supplying live biotherapeutic products. Meanwhile, Probi partnered on probiotic research for vaginal health NPD targeting the “underserved” market. Also, a Safefood report revealed that online conversations about healthy diets are missing input from health experts.
15 Feb 2021 --- During the last week, Evolve BioSystems landed US$55 million for the commercialization of its “next generation of probiotic.” Other top stories include Lonza’s US$4.7 billion sale of its Speciality Ingredients business and Kappa Bioscience’s US expansion of its vitamin K2 production.
25 Jan 2021 --- This week’s NutritionInsight NewsBite podcast looks into e-gaming’s emerging market potential. Recent business news highlights include Lonza’s exit from the softgel arena in the pharma market and other moves in the infant formula sector.
17 Aug 2022 --- Esports is one of the fastest-growing segments in the nutrition market. With nearly three billion active gamers globally, the time is now for brands to deliver innovative new products to professional esports gamers and fans alike.
05 Nov 2020 --- For today’s health-conscious and responsible consumers, Lonza’s Capsugel Plantcaps capsules provide the premier balance of product performance and convenience. This webinar dives into the latest market trends, as well as the science and regulatory landscape surrounding Plantcaps.
24 Jun 2020 --- Supplement users increasingly aspire to more sustainable, health-focused ideals and are on the hunt for high-quality, responsibly sourced products that help them to stay mobile and live better. In this webinar, Lonza experts delve into how these preferences extend across a range of emerging, on-demand consumer trends, from joint and cognitive health to probiotics and beauty-from-within.
08 Nov 2019 --- This webinar will discuss how food supplement makers can address the rising consumer demand for clean and clear label solutions in light of the changing regulatory environment regarding the use of titanium dioxide as an opacifier. It will also explore how Lonza’s new Vcaps® Plus WHITE OPAL® capsule is designed to perform and can support producers to meet this growing need in today’s market.
28 Mar 2019 --- The NutritionInsight webinar “Moving with the times: a new generation joint health solution for today’s consumer” offers insights into the changing consumer landscape, including the expectations of both aging and active consumers and rising demand for joint health solutions. Dominik Mattern of Lonza Capsugel discusses the science behind Lonza’s UC-II undenatured type II collagen ingredient, including its unique mode of action and how it can meet the needs of a new and growing consumer base. He presents a first look at Lonza’s new generation of ready-to-market innovative dosage forms and formulations that address mobility concerns related to healthy aging.
